Form 4: Fate Therapeutics Director William Rastetter Granted Stock Options

Director William H Rastetter of Fate Therapeutics received stock options for 40,000 shares on June 7, 2024, as part of the company's non-employee director compensation policy.

Summary

• William H Rastetter, a director at Fate Therapeutics, was granted stock options on June 7, 2024.
• The options are for 40,000 shares of Fate Therapeutics common stock.
• The exercise price of the options is $3.68 per share.
• The options vest on the earlier of June 7, 2025, or the date of the Issuer's 2025 Annual Meeting of Stockholders, contingent upon continued service on the Board of Directors.
• The grant was made under the Issuer's Amended and Restated Non-Employee Director Compensation Policy.

Sentiment

Score: 7

Explanation: The document reflects a routine compensation practice, indicating stability and alignment of interests. It's a neutral-positive event.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service on the board.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

Granting stock options to directors is a common practice in the biotechnology industry to align their interests with those of shareholders and incentivize long-term value creation.

Comparison to Industry Standards

• Stock option grants to non-employee directors are a standard component of compensation packages in the biotech industry.
• Comparable companies such as CRISPR Therapeutics and Editas Medicine also utilize equity grants as part of their director compensation.
• The size of the grant (40,000 shares) and the vesting schedule (one year) appear to be within the typical range for companies of Fate Therapeutics' size and stage.

Stakeholder Impact

• Shareholders may view the option grant positively as it aligns director interests with long-term company performance.
• The director is incentivized to contribute to the company's success to realize the value of the options.

Key Dates